Kirgen
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A biotech firm specializing in antibody development for therapeutics and diagnostics across multiple disease areas.
OncologyInfectious DiseasesImmunology
Technology Platform
Antibody discovery and engineering platform utilizing single B cell cloning and humanization for therapeutic and diagnostic applications.
Opportunities
Leveraging its diagnostic expertise to develop companion diagnostics could create synergies and add value to its therapeutic programs.
Risk Factors
Dilution of focus between service revenue and therapeutic R&D may slow progress in advancing its own drug candidates to the clinic.
Competitive Landscape
Competes in the fragmented antibody services market while also facing the high barriers of therapeutic antibody development against established players.